|
Rate constant for binding of Fab [fragment antigen-binding] fragments and recombinant domains of antibody D1.3 to its antigen
|
Mouse Mus musculus |
2×10^6 - 4×10^6 |
M^-1×sec^-1 |
112539 |
Northrup SH, Erickson... |
|
Number of antigen-receptor molecules on T cell surface
|
Human Homo sapiens |
30000 |
receptors/cell |
103567 |
Janeway's Immunobiology... |
|
Length of peptide used in MHC class 1 antigen presentation
|
Mammals |
8 - 9 |
residues |
109948 |
Kisselev AF, Akopian TN... |
|
Sensitivity of some methods for measuring antibody-antigen reactions
|
Unspecified |
Table - link |
μg antibody N/ml |
109494 |
Stewart Sell, Immunology... |
|
Rates of various steps that are involved in MHC class I antigen presentation
|
vertebrates |
Figure link |
N/A |
113774 |
Yewdell JW, Reits E,... |
|
Number of A, B, H and I antigen sites per red blood cell
|
Vertebrates |
2e+6 |
Antigen sites/cell |
106727 |
Anstee DJ. The functional... |
|
Number of Heat-stable antigen(hi) [HSA(hi)] splenic B cells
|
Mouse Mus musculus |
5×10^6 - 10×10^6 |
[HSA(hi)] cells/spleen |
113540 |
Allman DM, Ferguson SE... |
|
Estimated in vivo activities and copy number of molecules involved in MHC class-I-antigen presentation
|
vertebrates |
Table - link |
N/A |
113775 |
Yewdell JW, Reits E,... |
|
Typical area of interaction between receptor and a portion of the antigen (called epitope)
|
Unspecified |
600 |
Å^2 |
109929 |
Alan S. Perelson, Ge´rard... |
|
Antigen-specific memory B-cell frequencies estimated using polyclonal activation and EBV-B-cell immortalization
|
Human Homo sapiens |
Table - link |
N/A |
110222 |
Pinna D, Corti D, Jarrossay D... |
|
The relationship between the number of antigen-specific antibody secreting cells and the concentration of specific antibody from lymphocytes
|
Trout Oncorhynchus mykiss |
Table - link |
N/A |
108956 |
Bromage E, Stephens R... |
|
Time of transposition event that gave rise to the predecessors of the rearranging antigen-binding receptors of the jawed vertebrates
|
Vertebrates |
>500 |
Million years ago |
117054 |
Litman GW, Cannon JP... |
|
Effective Human Population Size according to Human Leukocyte Antigen system (HLA) interallelic data
|
Human Homo sapiens |
10000 |
Individuals |
104620 |
Hawks J, Hunley K, Lee SH... |
|
Fraction of lung cancers in which a mutation in p53 is found
|
Human Homo sapiens |
>50 |
% |
110653 |
Cairns J. Somatic stem... |
|
Duration between synthesis of MHC I W6/32 molecule and its appearance on cell surface
|
Human Homo sapiens |
1 |
Hour |
104754 |
Carreno BM, Hansen TH.... |
|
Reported elimination half-life (t½) and population pharmacokinetic (PopPK) parameters for monoclonal antibodies (mAbs)
|
Unspecified |
Table - link |
N/A |
112409 |
Keizer RJ, Huitema AD... |
|
Proportion of natural MHC class II ligands that are derived from cytosolic and nuclear proteins
|
vertebrates |
≤20 |
% |
113838 |
Schmid D, Pypaert M,... |
|
Time for peptide residue removal by cytosolic aminopeptidases
|
Mammals |
2 -3 |
sec/residue |
113773 |
Yewdell JW, Reits E,... |
|
Estimated overall efficiency of peptide generation for MHC class I molecules is on the order of
|
Unspecified |
1 |
per 10,000 proteins degraded |
113820 |
Yewdell JW, Reits E,... |
|
Thermodynamic parameters for burying a solvent-accessible phenyl group
|
vertebrates |
Table - link |
N/A |
109154 |
Kelley RF, O'Connell... |